WallStSmart

Semtech Corporation (SMTC)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Semtech Corporation generates 306% more annual revenue ($1.05B vs $258.90M). SMTC leads profitability with a -3.9% profit margin vs -15.5%. ZEPP earns a higher WallStSmart Score of 38/100 (F).

SMTC

Avoid

33

out of 100

Grade: F

Growth: 5.3Profit: 4.0Value: 4.3Quality: 5.8
Piotroski: 5/9Altman Z: 1.29

ZEPP

Hold

38

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

SMTCSignificantly Overvalued (-69.6%)

Margin of Safety

-69.6%

Fair Value

$52.21

Current Price

$119.19

$66.98 premium

UndervaluedFair: $52.21Overvalued
ZEPPUndervalued (+48.9%)

Margin of Safety

+48.9%

Fair Value

$46.96

Current Price

$18.01

$28.95 discount

UndervaluedFair: $46.96Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

SMTC0 strengths · Avg: 0/10

No standout strengths identified

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

SMTC4 concerns · Avg: 2.0/10
Price/BookValuation
20.1x2/10

Trading at 20.1x book value

Return on EquityProfitability
-7.4%2/10

ROE of -7.4% — below average capital efficiency

EPS GrowthGrowth
-32.7%2/10

Earnings declined 32.7%

Altman Z-ScoreHealth
1.292/10

Distress zone — elevated risk

ZEPP4 concerns · Avg: 2.3/10
Market CapQuality
$270.28M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Free Cash FlowQuality
$-26.48M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : SMTC

PEG of 1.21 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : SMTC

The primary concerns for SMTC are Price/Book, Return on Equity, EPS Growth.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

SMTC profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

SMTC carries more volatility with a beta of 2.06 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

SMTC generates stronger free cash flow (47M), providing more financial flexibility.

Bottom Line

ZEPP scores higher overall (38/100 vs 33/100) and 43.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Semtech Corporation

TECHNOLOGY · SEMICONDUCTORS · USA

Semtech Corporation designs, develops, manufactures, and markets mixed-signal and analog semiconductor products and advanced algorithms. The company is headquartered in Camarillo, California.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?